VA
MTCR

VR Adviser’s Metacrine, Inc. Common Stock MTCR Stock Holding History

VR Adviser’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-680,000
Closed -$4.22M – 36
2021
Q1 		$4.22M Sell
680,000
-13,673
-2% -$121K 0.46% 25
2020
Q4 		$5.45M Sell
693,673
-450,000
-39% -$4.13M 0.8% 21
2020
Q3 		$11.7M Buy
+1,143,673
New +$11.7M 2.28% 14

Other funds holding MTCR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VR Adviser's MTCR Position: Q2 2021 in Review

VR Adviser sold out of Metacrine, Inc. Common Stock (MTCR) in Q2 2021, closing a stake of 680,000 shares — an estimated $4.22M sold.

VR Adviser first reported a position in MTCR in Q3 2020 and held it in 3 quarters. The position peaked at $11.7M in Q3 2020. 42 funds tracked by Wall St. Rank hold MTCR as of Q2 2021.

  • VR Adviser reported no remaining Metacrine, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • VR Adviser sold 680,000 Metacrine, Inc. Common Stock shares in Q2 2021, an estimated $4.22M.
  • VR Adviser first reported a position in Metacrine, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • VR Adviser's Metacrine, Inc. Common Stock position peaked at $11.7M in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q2 2021.

Based on VR Adviser's 13F filing for Q2 2021, filed 13 Aug 2021.